Cogent Biosciences (COGT) total assets

Total assets · fiscal 2025
$937.61M

Cogent Biosciences (COGT) had total assets of $937.61M at the end of fiscal 2025 (December 31, 2025). That is 185.9% higher than the $327.90M of fiscal 2024. Figures as of 18 Nov 2026, 05:04 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$937.61M
Change on fiscal 2024
+185.9%
Growth, 5 years
+30.2% a year
Highest on record
$937.61Mfiscal 2025
Lowest on record
$49.12Mfiscal 2017
Fiscal years on record
92017–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Cogent Biosciences total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 30.2% a year. Across the 9 fiscal years on record (2017–2025), the highest was $937.61M in fiscal 2025 and the lowest $49.12M in fiscal 2017.

History · 9 fiscal years

Total assets by fiscal year

Cogent Biosciences total assets, year by year

Cogent Biosciences (COGT) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$937.61M 185.9% up
2024$327.90M 4.6% up
2023$313.44M 4.2% up
2022$300.81M 29.6% up
2021$232.09M 7.5% down
2020$250.92M 407.7% up
2019$49.42M 42.5% down
2018$85.93M 75.0% up
2017$49.12M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Cogent Biosciences and comparable companies
CompanyTotal assetsFiscal year
Teleflex TFX$6.95B2025
Mirum Pharmaceuticals MIRM$842.81M2025
Veradermics MANE$152.62M2025
Grifols GRFS€19.71B2025
Cogent Biosciences COGT$937.61M2025
GRAIL GRAL$2.92B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on COGT

Cogent Biosciences, figure by figure

Cogent Biosciences (COGT) overview: price, valuation and scorecardAll health care companies by market value

Cogent Biosciences total assets: questions and answers

How large are Cogent Biosciences's total assets?

Cogent Biosciences (COGT) had total assets of $937.61M at the end of fiscal 2025 (December 31, 2025). That is 185.9% higher than the $327.90M of fiscal 2024.

What is the growth rate of Cogent Biosciences's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 30.2% a year.

What are the highest and lowest total assets figures on record for Cogent Biosciences?

Across the 9 fiscal years on record (2017–2025), the highest was $937.61M in fiscal 2025 and the lowest $49.12M in fiscal 2017.

How is Cogent Biosciences's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cogent Biosciences (COGT) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/COGT/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.